Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin-based Chemotherapy vs Gemcitabine-Ifosfamide in Advanced NSCLC
NCT00622349Phase 3Completed
- Sponsor
- European Lung Cancer Working Party
- Start
- Feb 2004
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised trial of cisplatin in non-small cell lung cancer (NSCLC) (3 arms), sponsored by European Lung Cancer Working Party. Primary endpoint: Overall Survival. Started Feb 2004; status: completed.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00622349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622349.